Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Euvichol in Healthy Adults and Children
NCT02164110Phase 3Completed
- Sponsor
- EuBiologics
- Start
- May 2014
- Primary completion
- Sep 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Killed bivalent (O1 and O139) whole cell oral cholera vaccine in cholera, sponsored by EuBiologics. Started May 2014; status: completed.
02
Drugs
Killed bivalent (O1 and O139) whole cell oral cholera vaccine
03
Conditions
cholera
Beyond the preview
Go deeper on NCT02164110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164110.